Clinical Trials Advancement and Methods & Diversity and Disparities PIAs: Increasing sustained diversity in Alzheimer's disease and related dementia clinical trials.
Recorded: May 23, 2022
There is a need for AD clinical trials to improve recruitment, enrollment, and retention of diverse populations to ensure potential treatments are safe, effective, accessible, and equitable. Globalization of AD clinical trials is also discussed.
Moderators: Ganesh M Babulal, Jorge J Llibre-Guerra
Panelists: Erin Abner, Rufus Akinyemi, Suvarna Alladi, Sonia Brucki, Stephanie Monroe, Rema Raman
Closing Remarks: Bruce Miller